Back to search
FDAFDA · Food and drugs·Recall number D-0349-2024

Fluticasone Propionate Nasal Spray USP, 50 mcg per spray, 120 metered sprays, 16 g net fill, Rx only, Manufactured by: Apotek Inc., Toronto, Ontario, Cananda, Marketed by: GSMS Incorporated, Camarillo, CA, NDC 60429-195-15

Published March 6, 2024 · Recall initiated: February 14, 2024

Summary

FDA records drug Class II recall D-0349-2024, published March 6, 2024 and initiated February 14, 2024. Recalling firm: Golden State Medical Supply Inc.; Status: Ongoing; Reported quantity: 59,712 bottles; Lot: Lot #: TX5275, Exp. Date: 10/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations:Suspected potential presence of Burkholderia cepacia complex

What to do

Voluntary: Firm initiated · Letter

Get an email if FLUTICASONE PROPIONATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
FLUTICASONE PROPIONATE
Manufacturer
Golden State Medical Supply Inc.
Distributor
Nationwide in the USA
Lot
Lot #: TX5275, Exp. Date: 10/31/2026.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fluticasone Propionate Nasal Spray USP, 50 mcg per spray, 120 metered sprays, 16 g net fill, Rx only, Manufactured by: Apotek Inc., Toronto, Ontario, Cananda, Marketed by: GSMS Incorporated, Camarillo, CA, NDC 60429-195-15 recalled?

Yes. FDA published recall D-0349-2024 on March 6, 2024. Reported hazard: CGMP Deviations:Suspected potential presence of Burkholderia cepacia complex

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: FLUTICASONE PROPIONATE.